A case of angioimmunoblastic T cell lymphoma in a patient with ichthyosis |
Lee, Sang-Hyuk
(Department of Internal Medicine, Seoul Medical Center)
Lee, Jae-Myung (Department of Internal Medicine, Seoul Medical Center) Beom, Sun-Hee (Department of Internal Medicine, Seoul Medical Center) Hong, Suk-Ho (Department of Internal Medicine, Seoul Medical Center) Oh, So-Yeon (Department of Internal Medicine, Seoul Medical Center) |
1 | Günzel S, Weidenthaler B, Hausser I, Anton-Lamprecht I. Keratohyalin granules are heterogeneous in ridged and non-ridged human skin: evidence from antifilaggrin immunogold labeling of normal skin and skin of autosomal dominant ichthyosis vulgaris patients. Arch Dermatol Res 283:421-432, 1991 DOI ScienceOn |
2 | Yoon GS, Choi YK, Bak H, Kim BJ, Kim MN, Choi J, Rheu HM, Huh J, Choi JH, Chang SE. Angioimmunoblastic T cell lymphomas: frequent cutaneous skin lesions and absence of human herpes viruses. Ann Dermatol 21:1-5, 2009 DOI ScienceOn |
3 | Ko YH, Kim CW, Park CH, Jang HK, Lee SS, Kim SH, Ree HJ, Lee JD, Kim SW, Huh JR. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 83:806-812, 1998 DOI ScienceOn |
4 | Rizos E, Milionis HJ, Pavlidis N, Elisaf MS. Acquired ichthyosis: a paraneoplastic skin manifestation of Hodgkin's disease. Lancet Oncol 3:727, 2002 DOI ScienceOn |
5 | Rabhi M, Ennibi K, Harket A, Al Bouzidi A, Labraimi A, Chaari J, Toloune F. Acquired ichthyosis disclosing non-Hodgkin's malignant lymphoma. Intern Med 46:397-399, 2007 DOI ScienceOn |
6 | Brown HA, Macon WR, Kurtin PJ, Gibson LE. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression. J Cutan Pathol 28:432-438, 2001 DOI ScienceOn |
7 | Beak JH, Park SR, Choi IS, Kim SI, Kim DW, Kim JH, Yoon SS, Park SY, Kim BK, Kim NK, Heo DS. Angioimmunoblastic T-cell lymphoma: clinical characteristics and treatment outcomes. Korean J Hematol 40:8-14, 2005 DOI ScienceOn |
8 | Siegert W, Agthe A, Griesser H, Schwerdtfeger R, Brittinger G, Englhard M, Kuse R, Tiemann M, Lennert K, Huhn D. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen: a multicenter study. Ann Intern Med 117:364-370, 1992 DOI ScienceOn |
9 | Siegert W, Nerl C, Agthe A, Englehard M, Brittinger G, Tiemann M, Lennert K, Huhn D. Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma:prognostic impact of clinical observations and laboratory findings at presentation. Ann Oncol 6:659-664, 1995 |
10 | Pautier P, Devidas A, Delmer A, Dombret H, Sutton L, Zini JM, Nedelec G, Molina T, Marolleau JP, Brice P. Angioimmunoblasticlike T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 32:545-552, 1999 |
11 | KDA Textbook Editing Board. Dermatology. 5th ed. p. 112-118, Seoul, Ryo Moon Gak, 2008 |
12 | Nathwani BN, Rappaport H, Edgar MM, Pangalis GA, Kim H. Malignant lymphoma arising in angioimmunoblstic lymphadenopathy. Cancer 41:578-606, 1978 DOI ScienceOn |
13 | Knecht H. Angioimmunoblastic lymphadenopathy: ten years' experience and state of current knowledge. Semin Hematol 26: 208-215, 1989 |
14 | Williams ML. Ichthyosis: mechanisms of disease. Pediatr Dermatol 9:365-368, 1992 DOI ScienceOn |
15 | Shwayder T. Disorders of keratinization: diagnosis and management. Am J Clin Dermatol 5:17-29, 2004 DOI ScienceOn |